| 注册
首页|期刊导航|临床输血与检验|IL-32在不同分期哮喘患者血清中的表达比较

IL-32在不同分期哮喘患者血清中的表达比较

王恋 颜浩 王玉珠 何晨韵 吴驰 徐婷

临床输血与检验2018,Vol.20Issue(2):160-163,4.
临床输血与检验2018,Vol.20Issue(2):160-163,4.DOI:10.3969/j.issn.1671-2587.2018.02.016

IL-32在不同分期哮喘患者血清中的表达比较

A Comparative Study of IL-32 Concentration in Patients with Asthma of Various Phases

王恋 1颜浩 1王玉珠 1何晨韵 1吴驰 1徐婷1

作者信息

  • 1. 610017 四川省成都市第二人民医院呼吸内科
  • 折叠

摘要

Abstract

Objective To investigate the concentration and its significance of interleukin -32 (IL-32) in sera of patients with asthma. Methods One hundred and sixty five cases of asthma were selected,including 65 cases of acute attack,42 cases of chronic asthma and 58 stable phases and 50 healthy controls. Enzyme linked immunosorbent assay was used to detect serum IL-32. The respiratory function,the number of EOS,ECP level,and ACT score were measured and the correlation between IL-32 and the serum indicators was analyzed. Results IL-32 concentrations were found to be 53.87+20.07 ng/L,43.48+7.17 ng/L,29.55+6.26 ng/L,and 13.68+4.16 ng/L in acute,chronic and stable asthma,and healthy control, respectively (P<0.05). FEV1,FEV1/FVC and PEF increased while EOS and ECP decreased with remission of the disease. ACT score became high with amelioration. The concentration of IL32 in sera was negatively correlated with FEV1,FEV1/FVC and ACT,but positively correlated with EOS and ECP (P<0.05). No correlation of IL32 level in the sera was noted with PEF. Conclusion IL-32 is closely related to the occurrence and advance of asthma. Monitoring concentration of IL-32 in the sera of patients may help for the diagnosis,treatment and prognosis of asthma.

关键词

白细胞介素-32/哮喘/预后

Key words

Interleukin-32/Asthma/Prognosis

分类

医药卫生

引用本文复制引用

王恋,颜浩,王玉珠,何晨韵,吴驰,徐婷..IL-32在不同分期哮喘患者血清中的表达比较[J].临床输血与检验,2018,20(2):160-163,4.

基金项目

本课题受四川省卫生厅科研课题(No.120547)资助 (No.120547)

临床输血与检验

OACSTPCD

1671-2587

访问量0
|
下载量0
段落导航相关论文